WordNet

immunogen consisting of a suspension of weakened or dead pathogenic cells injected in order to stimulate the production of antibodies (同)vaccinum
relating to or caused by a virus; "viral infection"
inflammation of the liver caused by a virus or a toxin

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 成人におけるA型肝炎ウイルス感染の概要 overview of hepatitis a virus infection in adults
2. B型肝炎ウイルスワクチン hepatitis b virus vaccination
3. 小児および思春期における標準的予防接種 standard immunizations for children and adolescents
4. 慢性肝疾患患者のための予防接種 immunizations for patients with chronic liver disease
5. 幼児、小児および思春期におけるB型肝炎ウイルス予防接種 hepatitis b virus immunization in infants children and adolescents

Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.

Falson P1, Bartosch B2, Alsaleh K3, Tews BA3, Loquet A1, Ciczora Y3, Riva L3, Montigny C4, Montpellier C3, Duverlie G5, Pécheur EI1, le Maire M4, Cosset FL2, Dubuisson J6, Penin F7.
Journal of virology.J Virol.2015 Oct 15;89(20):10333-46. doi: 10.1128/JVI.00991-15. Epub 2015 Aug 5.
In hepatitis C virus (HCV)-infected cells, the envelope glycoproteins E1 and E2 assemble as a heterodimer. To investigate potential changes in the oligomerization of virion-associated envelope proteins, we performed SDS-PAGE under reducing conditions but without thermal denaturation. This revealed t
PMID 26246575

Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.

Reynolds TD1, Buonocore L1, Rose NF1, Rose JK1, Robek MD2.
Journal of virology.J Virol.2015 Oct 15;89(20):10407-15. doi: 10.1128/JVI.01184-15. Epub 2015 Aug 5.
More than 500,000 people die each year from the liver diseases that result from chronic hepatitis B virus (HBV) infection. Therapeutic vaccines, which aim to elicit an immune response capable of controlling the virus, offer a potential new treatment strategy for chronic hepatitis B. Recently, an evo
PMID 26246574

Recovery of infectious type Asia1 foot-and-mouth disease virus from suckling mice directly inoculated with an RNA polymerase I/II-driven unidirectional transcription plasmid.

Lian K1, Yang F1, Zhu Z1, Cao W1, Jin Y1, Li D1, Zhang K1, Guo J1, Zheng H2, Liu X1.
Virus research.Virus Res.2015 Oct 2;208:73-81. doi: 10.1016/j.virusres.2015.06.008. Epub 2015 Jun 16.
We developed an RNA polymerase (pol) I- and II-driven plasmid-based reverse genetics system to rescue infectious foot-and-mouth disease virus (FMDV) from cloned cDNA. In this plasmid-based transfection, the full-length viral cDNA was flanked by hammerhead ribozyme (HamRz) and hepatitis delta ribozym
PMID 26091821

中山哲夫
YAKUGAKU ZASSHI 131(12), 1723-1731, 2011
… Since 1930, aluminium salt has been used as DTaP (diphtheria-tetanus-acellular pertussis vaccine) adjuvant. … New adjuvant MF59, oil-in-water emulsion type, was developed for influenza vaccine for elderly (Fluad) and series of AS adjuvant are used for hepatitis B, pandemic flue, and human papiloma virus vaccines. …
NAID 130001871769

Randomized controlled study investigating viral suppression and serological response following pre-S1/pre-S2/S vaccine therapy combined with lamivudine treatment in HBeAg-positive patients with chronic hepatitis B.

Hoa Pham Thi Le,Huy Nguyen Tien,Thu Le The,Nga Cao Ngoc,Nakao Kazuhiko,Eguchi Katsumi,Chi Nguyen Huu,Hoang Bui Huu,Hirayama Kenji
Antimicrobial agents and chemotherapy 53(12), 5134-5140, 2009-12
… The aim of the current study was to evaluate viral suppression following combined treatment with an S/pre-S1/pre-S2 vaccine and lamivudine in patients with chronic hepatitis B. … We established a randomized, controlled clinical trial to compare the responses of three different treatment groups: those receiving vaccine monotherapy, lamivudine monotherapy, or combination treatment. …
NAID 120001759344